BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 

Thursday, April 17, 2014
 
GlaxoSmithKline (GSK), Genmab A/S (GEN.CO) Wins FDA Approval For Arzerra As First-Line Treatment For Chronic Lymphocytic Leukaemia (CLL)    More...

FDA OKs Merck & Co., Inc. (MRK) Tablet To Reduce Ragweed Allergies    More...

Albany Molecular Research, Inc. (AMRI) (AMRI) Shutters New York Research Center, Cuts 45 Jobs    More...

One Of A Kind Trial To Test 14 AstraZeneca PLC (AZN), Pfizer Inc. (PFE) Drugs At The Same Time    More...

San Diego's Vital Therapies, Inc. (VTI) (VTL) Prices $54 Million IPO    More...

GlaxoSmithKline (GSK) Investigating Bribery Claims In Jordan And Lebanon    More...

AstraZeneca PLC (AZN) Opens Vast Library To Researchers But Gets First Dibs On New Drugs    More...

Nora Therapeutics Announces $18 Million Series B Financing    More...

 
More Breaking News



 
Stolen Roche (RHHBY) Cancer Drug Found On Market    More...

Lucky Drug Made Pharmacyclics, Inc. (PCYC)' Robert Duggan A Billionaire—Can He Do It Again?    More...

Boehringer Ingelheim Corporation Rethinks Hepatitis Business, Braces For A Rough 2014    More...

Viagra Ice Cream: New Flavor Contains Sildenafil Citrate    More...

San Diego Accelerator HardTech Labs Chooses 4 Startups To Be Guinea Pigs    More...

Novartis AG (NVS) Thinks Twice About RNAi Development, Slims Down R&D Group In Boston    More...

Novartis AG (NVS) To Lay Off 215 NJ Support Staff Employees    More...

Boston-Based EPIRUS Biopharmaceuticals Reels In $36 Million Series B, Will Merge With Zalicus Inc. (ZLCS) In All-Stock Deal    More...

Baxter International, Inc. (BAX) Drug BAX 111 Treats 100 Percent Of Bleeding Episodes In Small Phase 3 Trial    More...

Novartis AG (NVS) Overtakes Pfizer Inc. (PFE) As Top Drug Company    More...

 
More News

Did Chimerix, Inc. Set A Bad Example For Biopharma? </b>Did Chimerix, Inc. Set A Bad Example For Biopharma?

Chimerix generated some pretty negative publicity when it denied a dying seven-year old boy access to its experimental drug brincidofovir. Josh Hardy had developed an adenovirus infection following a bone marrow transplant related to past cancer treatment. Since Chimerix has a drug that has demonstrated some efficacy (albeit much of it anecdotal) in exactly this indication, doctors recommended the parents see about getting the medicine on a "compassionate use" basis. The company, however, demurred. More...
Executive Jobs
DepomedChief Medical Officer
CelgeneVice President, Global Medical Affairs
Novartis Institutes for BioMedical ResearchGlobal HR Partner, Executive Director
HospiraMedical Director, Biologics Medical Affairs

Search Jobs


Miles
Km80.5


 
Drugs To Watch: Potential Blockbusters Of 2014    More...
Once a Notorious Short Seller, Martin Shkreli Now Sees A Future In Biotech    More...
Is Your Kitchen Making You Sick? University Hospital in Basel Study    More...
Discovered—Scientists Unravel Mystery Of How Sperm Recognizes Eggs, Wellcome Trust Sanger Institute Study    More...
Mom's Weight Linked To Stillbirth, Infant Death Risks, Imperial College London Study    More...
Antibiotics Increase Growth In Undernourished Kids, McGill University Study    More...
Lack Of Emotion And Interest May Signal Your Brain Is Shrinking, National Institutes of Health (NIH) Study    More...
Feminine Girls, Masculine Boys Have Higher Cancer Risk, Harvard School of Public Health Study    More...
 
More Featured News


 

Known for its scientific and operational excellence, Regeneron is a leading science-based biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron markets medicines for eye diseases, colorectal cancer, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, oncology, rheumatoid arthritis, allergic asthma, and atopic dermatitis.


Show me jobs for this employer
 
Feature Employer
 
Emerging Job Search Trends In 2014    More...

Hiring Managers Reveal The 15 BEST Words To Use On Your Resume    More...

10 Interview Questions; The Good, Bad, And The Ugly    More...

What Your Body Language Is Saying During The Interview    More...

The 2 Stages Of Job Search Rejection    More...

5 Resume Errors That Will Land You In The Trash    More...

5 Rules Of Employment Follow-Up    More...

3 Executive Resume Bloopers You’re Making Right Now    More...

3 Secrets To Interview-Winning Cover Letters    More...

6 Ways To Handle Irritating Colleagues    More...

 
More Career Tips



//-->